Biotech · Private company
QED Therapeutics, a BridgeBio company
Track this companyFree. Adds QED Therapeutics, a BridgeBio company to your Dealase workspace and tells you when its record changes.
Clinical trials135 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- BGJ398Phase 3 · Advanced CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 3 · Advanced CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 3 · Advanced CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- InfigratinibPhase 3 · Upper Tract Urothelial CarcinomasClinicalTrials.gov · fetched Nov 12, 2026
- infigratinib 0.128 mg/kg/dayPhase 3 · HypochondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- infigratinib 0.25 mg/kg/dayPhase 3 · HypochondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Infigratinib 0.25 mg/kg/dayPhase 3 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- BGJ398 (infigratinib)Phase 2 · Advanced CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- InfigratinibPhase 2 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- InfigratinibPhase 2 · HypochondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Infigratinib 0.016 mg/kgPhase 2 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Infigratinib 0.032 mg/kgPhase 2 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Infigratinib 0.064 mg/kgPhase 2 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Infigratinib 0.128 mg/kgPhase 2 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Infigratinib 0.25 mg/kgPhase 2 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Infigratinib is provided as a single dose of minitablets for oral administrationPhase 2 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
- Infigratinib is provided as sprinkle capsules for daily oral administrationPhase 2 · AchondroplasiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- Open-Label, Long-Term, Extension Study of Infigratinib in Children With HypochondroplasiaPHASE2 · ENROLLING_BY_INVITATION · started Apr 23, 2026ClinicalTrials.gov NCT07393373 · fetched Nov 12, 2026
- Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)PHASE2 · RECRUITING · started Nov 19, 2025ClinicalTrials.gov NCT07169279 · fetched Nov 12, 2026
- An Interventional Study of Infigratinib in Children With HypochondroplasiaPHASE2_PHASE3 · ENROLLING_BY_INVITATION · started Apr 22, 2025ClinicalTrials.gov NCT06873035 · fetched Nov 12, 2026
- Prospective Clinical Assessment Study in Children With HypochondroplasiaRECRUITING · started Jun 5, 2024ClinicalTrials.gov NCT06410976 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With AchondroplasiaPHASE3 · COMPLETED · started Nov 10, 2023ClinicalTrials.gov NCT06164951 · fetched Nov 12, 2026
- Extension Study of Infigratinib in Children With Achondroplasia (ACH)PHASE2 · ENROLLING_BY_INVITATION · started Dec 6, 2021ClinicalTrials.gov NCT05145010 · fetched Nov 12, 2026
- Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerPHASE1 · TERMINATED · started Oct 13, 2020ClinicalTrials.gov NCT04504331 · fetched Nov 12, 2026
- Infigratinib in Recurrent High-Grade Glioma PatientsEARLY_PHASE1 · TERMINATED · started Jul 21, 2020ClinicalTrials.gov NCT04424966 · fetched Nov 12, 2026
- Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic AlterationsPHASE3 · TERMINATED · started Mar 11, 2020ClinicalTrials.gov NCT04197986 · fetched Nov 12, 2026
- Study of Infigratinib in Children With AchondroplasiaPHASE2 · COMPLETED · started Mar 10, 2020ClinicalTrials.gov NCT04265651 · fetched Nov 12, 2026
- Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/TranslocationsPHASE3 · TERMINATED · started Dec 27, 2019ClinicalTrials.gov NCT03773302 · fetched Nov 12, 2026
- Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)COMPLETED · started Aug 12, 2019ClinicalTrials.gov NCT04035811 · fetched Nov 12, 2026
- A Phase II, Single Arm Study of BGJ398 in Patients With Advanced CholangiocarcinomaPHASE2 · TERMINATED · started Jul 23, 2014ClinicalTrials.gov NCT02150967 · fetched Nov 12, 2026